Ozempic®, Wegovy®, Rybelsus®, and Mounjaro™ have been investigated for failing to warn that these popular diabetes drugs, which are also gaining popularity for aiding in weight loss, are causing gastroparesis, which is a paralysis of the stomach. A drug injury attorney can help with a claim.
Gastroparesis is defined as a disorder that slows or stops the movement of foods from the stomach to the small intestine. Gastroparesis can interfere with normal digestion causing nausea, bloating, vomiting, and abdominal pain. The manufacturers of Ozempic®, Wegovy®, Rybelsus®, and Mounjaro™ did not include warnings about the increased risk of gastroparesis for people who use these medications, which opens them up for potential liability.
Mounjaro™, Rybelsus®, and Ozempic® are FDA‑approved diabetes medications, while Wegovy® is FDA‑approved specifically for weight loss. Brayton Purcell is currently investigating cases involving these drugs manufactured by Novo Nordisk and Eli Lilly and Co. that meet the following criteria:
- Potential client must be 75 years old or younger
- Potential client must have taken pills or injections
- Potential client must have received a diagnosis of gastroparesis, stomach paralysis or gastric obstruction while taking these drugs or within 30 days of stopping use
- Potential client must have experienced extended periods of vomiting while taking these drugs or within 30 days of stopping use
- Potential client must have required an emergency room visit or hospital admission
When you believe you or someone you know has experienced gastroparesis or other severe side effects as a result of taking Ozempic®, Wegovy®, Rybelsus®, and Mounjaro™ and are considering legal action, we strongly recommend consulting with us regarding how we can assist you.
